Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.
Condition(s):Circulating Tumor Cells; Pancreatic Adenocarcinoma; Circulating Tumor DNA (KRAS); CA 19.9Last Updated:May 29, 2018Recruiting
Hide Studies Not Open or Pending
Condition(s):Circulating Tumor Cells; Pancreatic Adenocarcinoma; Circulating Tumor DNA (KRAS); CA 19.9Last Updated:May 29, 2018Recruiting
Condition(s):Pancreas AdenocarcinomaLast Updated:January 13, 2021Recruiting
Condition(s):Pancreatic AdenocarcinomaLast Updated:July 17, 2018Unknown status
Condition(s):Pancreatic AdenocarcinomaLast Updated:May 28, 2019Completed
Condition(s):Pancreatic AdenocarcinomaLast Updated:January 10, 2013Completed
Condition(s):Pancreatic AdenocarcinomaLast Updated:August 4, 2014Unknown status
Condition(s):Pancreatic AdenocarcinomaLast Updated:May 21, 2020Active, not recruiting
Condition(s):Pancreatic AdenocarcinomaLast Updated:July 26, 2017Recruiting
Condition(s):Metastatic Pancreatic AdenocarcinomaLast Updated:May 4, 2016Completed
Condition(s):Pancreatic AdenocarcinomaLast Updated:September 13, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.